Choi, Jung-Hyun http://orcid.org/0000-0001-6941-463X
Correia de Sousa, Jaime http://orcid.org/0000-0001-6459-7908
Fletcher, Monica http://orcid.org/0000-0002-9700-3552
Gabutti, Giovanni http://orcid.org/0000-0002-7259-4923
Harrington, Lauriane http://orcid.org/0000-0001-6765-8606
Holden, Michael http://orcid.org/0000-0001-9454-6159
Kim, Hyungwoo http://orcid.org/0000-0001-8675-0192
Michel, Jean-Pierre http://orcid.org/0000-0003-0718-4394
Mukherjee, Piyali http://orcid.org/0000-0002-9895-3795
Nolan, Terry http://orcid.org/0000-0001-6018-3863
Welte, Tobias http://orcid.org/0000-0002-9947-7356
Maggi, Stefania http://orcid.org/0000-0002-0453-8663
Funding for this research was provided by:
GlaxoSmithKline
University of Geneva
Article History
Received: 8 September 2021
Accepted: 24 October 2021
First Online: 10 January 2022
Declarations
:
: LH, PM, and HK are employees of the GSK group of companies. PM report ownership of shares and/or restricted shares of the GSK group of companies. TN reports personal fees from GSK during the conduct of the study and personal fees from GSK, outside the submitted work. GG reports personal fees from GSK, Sanofi Pasteur Italy, MSD, Merck, Pfizer, Seqirus and Emergent Biosolutions, outside the submitted work. SM reports grants from GSK, MSD, Takeda and Sanofi, and personal fees from GSK, outside the submitted work. HK reports other relationships with GSK, during the conduct of the study. TW reports grants from the German Ministry of Research and Education, and personal fees from GSK, MSD, AstraZeneca, BioNTech, Pfizer, Johnson&Johnson, during the conduct of the study. JCdS reports personal fees from AstraZeneca and Mundipharma, non-financial support from AstraZeneca and other relationships with Boheringer Ingelheim, GSK, AstraZeneca, Mundipharma, Bial and Novartis, outside the submitted work. JHC, MF, MH and JPM have nothing to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.